Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001213900-25-072158·Mural Oncology plc
Schedule 13G ownership disclosure
MURAL ONCOLOGY PUB LTD CO
Ordinary Shares, nominal value $0.01 per share · CUSIP: G63365103
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Soleus Capital Master Fund, L.P.
Shares: 1,323,877.00 · Class: 7.6%
- Soleus Capital, LLC
Shares: 1,323,877.00 · Class: 7.6%
- Soleus Capital Group, LLC
Shares: 1,323,877.00 · Class: 7.6%
- Soleus Capital Management, L.P.
Shares: 1,323,877.00 · Class: 7.6%
- Soleus GP, LLC
Shares: 1,323,877.00 · Class: 7.6%
- Guy Levy
Shares: 1,323,877.00 · Class: 7.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-072158
- Form type
- SCHEDULE 13G/A
- Filer
- Mural Oncology plc
- CIK
- CIK 1971543
- Filed
- Aug 05, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership